XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 24 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Dec. 31, 2021
Dec. 31, 2020
Statement of Cash Flows [Abstract]        
Net earnings $ 4,028 $ 7,984    
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:        
Depreciation and amortization 8,832 9,209    
Amortization of debt issuance costs 442 424    
Accretion of convertible notes discount 0 738    
Provision for doubtful accounts 135 173    
Gain (Loss) on Disposition of Business 0 234    
Net loss on sale of assets 60 10    
Net loss on derivative instruments 449 590    
Stock compensation expense 2,081 1,743    
Deferred income taxes (1,247) 1,793    
Changes in assets and liabilities, excluding effects of acquisitions/divestitures:        
Accounts receivable 4,307 50,254    
Increase (Decrease) in Contract with Customer, Asset 12,973 (5,704)    
Contract costs 144 (432)    
Inventories (17,285) (13,655)    
Income tax refunds receivable (410) 418    
Operating Right-of-Use Assets 915 799    
Other assets (2,249) 1,042    
Accounts payable - trade (612) (14,707)    
Contract liabilities (137) (5,439)    
Operating Lease Liabilities (899) (908)    
Payments for Retention Plans 0 (25,108)    
Other current liabilities (10,581) (6,796)    
Income taxes payable 53 1,173    
Pension liabilities (1,876) (5,452)    
Increase (Decrease) in Other Noncurrent Liabilities (140) (798)    
Net cash provided by operating activities (1,017) (2,415)    
Cash flows from investing activities:        
Payments for (Proceeds from) Businesses and Interest in Affiliates 0 (3,428)    
Expenditures for property, plant & equipment (6,877) (4,678)    
Other, net 424 6    
Net cash used in investing activities (6,453) (8,100)    
Cash flows from financing activities:        
Purchase of treasury shares (575) (344)    
Dividends paid (5,572) (5,545)    
Other, net 2,112 1,205    
Net cash provided by (used in) financing activities (4,035) (4,684)    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect (11,505) (15,199)    
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (198) (166)    
Cash and cash equivalents at beginning of period       $ 136,089
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 129,097   $ 140,800  
Cash and cash equivalents and restricted cash at end of period $ 129,097 $ 120,724 $ 140,800